Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, November 10, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant
Life Sciences Times
-
November 10, 2025
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
Pharma
Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement
Life Sciences Times
-
October 6, 2022
0
Pharma
Massive Bio and Perthera.ai Partner to Empower Cancer Patients with Personalized Therapies and Accurate Trial Recommendations
Life Sciences Times
-
October 5, 2022
0
Pharma
Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine
Life Sciences Times
-
October 3, 2022
0
Pharma
Scientists Create Non-Psychedelic Compound with Same Anti-depressant Effect
Life Sciences Times
-
September 28, 2022
0
Pharma
CinRx Pharma Announces First Study Participant Dosed in CinFina’s Phase I Multiple Ascending Dose (MAD) Study of CIN-109 for the Treatment of Obesity
Life Sciences Times
-
September 28, 2022
0
Pharma
Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer
Life Sciences Times
-
September 27, 2022
0
Pharma
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years...
Life Sciences Times
-
September 26, 2022
0
Pharma
Aptar Expands Pharmaceutical Services; Announces Exclusive Collaboration Between Aptar Pharma and Fluidda
Life Sciences Times
-
September 22, 2022
0
Pharma
University of Maryland School of Pharmacy Taps Komodo Health Platform To Power Real-World Evidence Research
Life Sciences Times
-
September 21, 2022
0
Pharma
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Versions of TAZORAC® (tazarotene) gel, 0.05% and 0.1%, with 180 days Competitive Generic Therapy...
Life Sciences Times
-
September 20, 2022
0
Pharma
Alnylam and Regeneron Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Life Sciences Times
-
September 15, 2022
0
Pharma
Inversago Pharma receives IND clearance for Phase 2 trial of INV-202 in Diabetic Kidney Disease
Life Sciences Times
-
September 15, 2022
0
1
...
39
40
41
...
83
Page 40 of 83
Most Read
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
November 10, 2025
Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals
November 10, 2025
Dr. Nina Kottler Named Chief Medical AI Officer of Mosaic Clinical Technologies
November 10, 2025
Kaneka Expands Global Availability of i-ED Coil with European Launch
November 10, 2025